Panasonic Holdings Corp., Shinobi Therapeutics and Center for iPS Cell Research and Application Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology
April 18, 2024 at 09:00 am EDT
Share
Shinobi Therapeutics announced a partnership with Panasonic Holdings Corp. and Kyoto University's Center for iPS Cell Research and Application (CiRA). Through this strategic collaboration, the organizations aim to engineer a novel manufacturing platform to produce iPS-T cell therapies more efficiently and at lower cost than is possible with currently available technology.
Cell therapies have shown remarkable promise in treating blood cancers and other intractable diseases, but manufacturing costs render these therapies inaccessible to many patients around the world. Shinobi's iPS-T cell technology, built upon a decade's worth of iPSC research pioneered at CiRA by Shinobi co-founder Shin Kaneko using iPSCs originally created by Nobel laureate Shinya Yamanaka, will be used to support the creation of a closed-system manufacturing device created by Panasonic, opening up an entirely new paradigm for cell therapy production. The newly announced partnership will leverage Panasonic's manufacturing expertise to develop a new method of producing iPS-T cell therapies in a closed-system process.
The first phase of the partnership will be completed in April 2025, when the companies expect to release the initial prototype.
Panasonic Holdings Corporation (formerly Panasonic Corporation) specializes in manufacturing and marketing of consumer electronic equipments. Net sales (including intragroup) break down by family of products as follows:
- domestic equipments, appliances and audiovisual equipment (42.5%): lighting devices, photovoltaic devices, wiring devices, health and care devices, furnishing materials, air conditioning and ventilation equipments, air purifiers, refrigerators, air conditioners, washing machines, dryers, vacuum cleaners, irons, microwaves, fans, cooking appliances, dishwashers, TVs, digital cameras, audio and video equipment, fixed telephones, showcases, etc.;
- electronic and electromechanical components (13.2%): relays, switches, power supply systems, industrial motors and sensors, capacitors, coils, resistors, materials for electronic circuits, semiconductors, LCD panels, etc.;
- automotive multimedia equipment and electronic accessories (12.4%);
- avionics, industrial automation, communication and entertainment systems (10.8%): in-flight entertainment and communication systems, electronic component assembly machines, welding equipment, projectors, professional audio-visual systems, computers, tablets, mobile communication systems and equipment, etc.;
- energy storage systems (8.9%): cylindrical lithium-ion batteries, dry batteries, primary/secondary lithium batteries, nickel-metal hydride batteries, lithium-ion batteries, energy storage modules and systems;
- other (12.2%).
Net sales break down geographically as follows: Japan (43.2%), China (13.4%), Asia (14.7%), Americas (18.7%) and Europe (10%).
Panasonic Holdings Corp., Shinobi Therapeutics and Center for iPS Cell Research and Application Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology